Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 16/20 | 0.49 |
| ▸ | ITGA2B | P08514 | 16/20 | 0.49 |
| ▸ | PREP | P48147 | 2/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7295450 | 0.94 | PREP (0.45) | ITGB3ITGA2BPREPSIGMAR1 | |
| SCHEMBL7311516 | 0.90 | ITGB3 (0.46) | ITGB3ITGA2BPREPSIGMAR1 | |
| SCHEMBL7287855 | 0.86 | ITGB3 (0.52) | ITGB3ITGA2BPREP | |
| SCHEMBL8619569 | 0.86 | SIGMAR1 (0.44) | ITGB3ITGA2BPREPSIGMAR1 | |
| SCHEMBL7285021 | 0.86 | SIGMAR1 (0.44) | ITGB3ITGA2BPREPSIGMAR1 | |
| SCHEMBL7286648 | 0.85 | ITGB3 (0.43) | ITGB3ITGA2BPREPSIGMAR1 | |
| SCHEMBL7284719 | 0.84 | ITGB3 (0.43) | ITGB3ITGA2BPREPSIGMAR1 | |
| SCHEMBL7276265 | 0.84 | ITGB3 (0.49) | ITGB3ITGA2BPREPSIGMAR1 | |
| SCHEMBL7296887 | 0.84 | PREP (0.43) | ITGB3ITGA2BPREPSIGMAR1 | |
| SCHEMBL7286805 | 0.84 | PREP (0.43) | ITGB3ITGA2BPREPSIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0822931-A1 | PIPERAZINONES USEFUL AS INHIBITORS OF PLATELET AGGREGATION | Takeda Chemical Industries, Ltd. (JP) | 1998-02-11 | — | — | EP | disclosed |
| WO-1996033982-A1 | PIPERAZINONES USEFUL AS INHIBITORS OF PLATELET AGGREGATION | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-10-31 | — | — | WO | disclosed |